A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)

NCT07734610 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Renal Impairment
Healthy

Interventions

DRUG: Nemtabrutinib

Sponsor

Merck Sharp & Dohme LLC